Moderna【MRNA】銘柄情報

	リアルタイム株価	レベル2
Forex

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

43.06

買値

43.00

売値

43.38

出来高

3,476,060

42.30 日の範囲 43.85

35.80 52 週間の範囲 170.47

時価総額

16.57B

前日終値

43.39

始値

43.25

時刻

43.05

最終取引時間

財務取引量

US$ 150,597,112

VWAP

43.3241

平均取引量 (3 か月)

7,342,796

発行済株式数

384,817,811

配当利回り

PER

-3.52

1 株当たり利益 (EPS)

-12.25

歳入

6.85B

純利益

-4.71B

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of ... Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases. 詳細を表示

セクター

Biological Pds,ex Diagnstics

業界

Biological Pds,ex Diagnstics

ウェブサイト

www.modernatx.com

本社

Wilmington, Delaware, USA

設立

Moderna Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker MRNA. The last closing price for Moderna was US$43.39. Over the last year, Moderna shares have traded in a share price range of US$ 35.80 to US$ 170.47.

Moderna currently has 384,817,811 shares in issue. The market capitalisation of Moderna is US$16.70 billion. Moderna has a price to earnings ratio (PE ratio) of -3.52.

全体の流れ

ベアリッシュ

ネットプレミアム

-651M

Calls / Puts

15.05%

買い / 売り

80.70%

OTM / ITM

21.59%

Sweeps比率

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)

The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program, as the third Phase 3 trial for the investigational individualized neoantigen therapy, V940...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	4.62	12.0187304891	38.44	46.3	37.76	10928367	42.17026395	CS
4	-11.43	-20.9763259314	54.49	56.695	35.8	11086574	43.00055945	CS
12	-30.38	-41.3671023965	73.44	79.9587	35.8	7342796	53.02017198	CS
26	-106.94	-71.2933333333	150	158.82	35.8	5501461	74.77332989	CS
52	-35.8	-45.3969059092	78.86	170.47	35.8	4994479	88.17931174	CS
156	-326.74	-88.3558680368	369.8	376.4118	35.8	5250484	139.62701237	CS
260	22.46	109.029126214	20.6	497.17	17.68	9229237	146.03273499	CS

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
BSLKBolt Projects Holdings Inc	US$ 0.71 (139.86%)	80.81M
PRZOParaZero Technologies Ltd	US$ 1.24 (94.14%)	205.02M
AIEVThunder Power Holdings Inc	US$ 0.47 (87.25%)	122.71M
PASGPassage Bio Inc	US$ 1.13 (69.52%)	15.44M
EPOWSunrise New Energy Company Ltd	US$ 1.06 (45.21%)	314.9k
APLTApplied Therapeutics Inc	US$ 2.03 (-76.31%)	43.9M
TGLTreasure Global Inc	US$ 0.2944 (-29.08%)	1.85M
PROCProcaps Group SA	US$ 1.51 (-27.75%)	106.08k
SHOTWSafety Shot Inc	US$ 0.104 (-20.00%)	1.43k
MONDMondee Holdings Inc	US$ 0.7102 (-19.59%)	297.63k
PRZOParaZero Technologies Ltd	US$ 1.24 (94.14%)	202.48M
NVDANVIDIA Corporation	US$ 138.25 (2.15%)	140.34M
AIEVThunder Power Holdings Inc	US$ 0.47 (87.25%)	122.71M
RGTIRigetti Computing Inc	US$ 3.05 (27.08%)	115.6M
MARAMARA Holdings Inc	US$ 27.42 (1.86%)	88.39M